6533b82ffe1ef96bd1295cd2
RESEARCH PRODUCT
Cellular and humoral immune responses against cancer: implications for cancer vaccines.
Thomas WölfelAlexander KnuthKarl-hermann Meyer Zum Büschenfeldesubject
Antibodies Neoplasmmedicine.medical_treatmentImmunologyBiologyMajor histocompatibility complexMiceImmune systemAntigenAntigens NeoplasmGangliosidesNeoplasmsmedicineImmunology and AllergyAnimalsHumansVector (molecular biology)Immunity CellularLymphokinesVaccinesVaccines SyntheticCancerNeoplasms Experimentalmedicine.diseaseCTL*ImmunologyAntibody Formationbiology.proteinBCG VaccineCytokinesTumor necrosis factor alphaAdjuvantT-Lymphocytes Cytotoxicdescription
The key issue in tumor immunology is to identify antigens as target structures for a cancer-selective immunological attack in the tumor-bearing host, resulting in tumor rejection. There is a growing detailed understanding of structural and regulatory gene alterations giving rise to candidate rejection antigens and peptides in tumor cells. As well as reviewing the development of new adjuvant and recombinant vector systems, new approaches are suggested for the construction of cancer vaccines.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 1991-10-01 | Current opinion in immunology |